Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells.
Year: 2001
Type: article
Source: PubMed
Authors: M A Molina, J Codony-Servat, J Albanell, F Rojo, J Arribas, J Baselga
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2168106779